Author:
Holmes David R.,Kereiakes Dean J.,Laskey Warren K.,Colombo Antonio,Ellis Stephen G.,Henry Timothy D.,Popma Jeffrey J.,Serruys Patrick W.J.C.,Kimura Takeshi,Williams David O.,Windecker Stephan,Krucoff Mitchell W.
Subject
Cardiology and Cardiovascular Medicine
Reference82 articles.
1. U.S. Food and Drug Association. FDA advises physicians of adverse events associated with Cordis Cypher coronary stents U.S. Food and Drug Administration Public Health Web Notification. Available at: http://www.fda.gov/bbs.topics/ANSWERS/2003/ANS01257.html. Accessed October 29, 2003.
2. Concerns prompt some hospitals to pare use of drug-coated stents;Westphal;Wall Street Journal,2006
3. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents;Iakovou;JAMA,2005
4. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy;McFadden;Lancet,2004
5. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?;Virmani;Circulation,2004
Cited by
104 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献